Clinical Trial Update: The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (EFFEKTOR) is evaluating finerenone in kidney transplant recipients, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Kidney Transplantation
• Kidney Transplantation

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Kidney Transplant; Complications | Phase 2 | Status: RECRUITING